Аногенитальная герпетическая вирусная инфекция

1. Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011;305:1441–1449.

2. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770–775.

3. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197–202.

4. Cherpes TL, Meyn LA, Hillier SL. 2005. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis 32:84–89.

5. Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003;30:174–177.

6. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444–1449.

7. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958– 972.

8. Mindel A, Carney O, Williams P. Cutaneous herpes simplex infections. Genitourin Med 1990;66:14–15.

9. Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека. Руководство для врачей. СПб.: Спецлит, 2006: 302 с.

10. Баринский И.Ф., Махмудов Ф.Р. Герпес. Баку: Victory, 2013:352 с.

11. Халдин А.А., Игнатьев Д.В., Васильев А.Н. Простой герпес: этиология, патогенез, диагностика, лечение. Дерматология. Приложение к журналу Consilium Medicum. 2009; 1: С. 35 – 39.

12. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect 2002; 78: Р.160 – 165.

13. Wald A., Huang M.-L., Carrell D. et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003; 188: P. 1345 – 3151.

14. Geretti A.M. Brown D.W. National survey of diagnostic services for genital herpes. Sex Transm Infect 2005; 81: Р.316 – 317. 21

15. Gupta R, Warren T and Wald A. Genital herpes. Lancet 2007; 370: 2127–2137.

16. Legoff J, Tanton C, Lecerf M, Grésenguet G, Nzambi K, Bouhlal H, Weiss H, Belec L. Influence of storage temperature on the stability of HIV-1 RNA and HSV-2 DNA in cervicovaginal secretions collected by vaginal washing. J Virol Methods. 2006 Dec; 138(1- 2):196-200.

17. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992; 326: 1533–1539.

18. Ramaswamy M, McDonald C, Smith M, et al. Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect 2004; 80: 406–410.

19. van Doornum GJ, Guldemeester J, Osterhaus AD, et al. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003; 41:576–580.

20. Van Der Pol B, Warren T, Taylor SN, Martens M, Jerome KR, Mena L, Lebed J, Ginde S, Fine P, Hook EW III. Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test. J Clin Microbiol 2012;50:3466–3471.

21. Casper C and Wald A. Condom use and the prevention of genital herpes acquisition. Herpes 2002; 9: 10–14.

22. Munday PE, Vuddamalay J, Slomka MJ, et al. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes. Sex Transm Infect 1998; 74: 175–178. 23. Ashley RL and Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12: 1–8.

24. Delaney S, Gardella C, Daruthayan C, Saracino M, Drolette L, Corey L, Wald A. A prospective cohort study of partner testing for herpes simplex virus and sexual behavior during pregnancy.. J Infect Dis. 2012; 206 : 486–494.

25. Gardella CB,Z, Wald A, Selke S, Zeh J, Morrow RA, Corey L. Risk factors for herpes simplex virus transmission to pregnant women: a couples study. Am J Obstet Gynecol. 2005;193:1891–9.

26. Gardella C, Krantz E, Daruthayan C, Drolette L, Corey L, Wald A. The acceptance of HSV-testing partners of HSV-2 seronegative women. Sex Transm Dis. 2009;36:211–5. 27. Malkin JE. Herpes simplex virus: who should be tested? Herpes 2002; 9: 31.

28. Copas AJ, Cowan FM, Cunningham AL, et al. An evidence based approach to testing for antibody to herpes simplex virus type 2. Sex Transm Infect 2002; 78: 430–434. 22

29. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350: 11–20.

30. Ramaswamy M, McDonald C, Sabin C, et al. The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London. Sex Transm Infect 2005; 81: 306–308.

31. Arshad Z, Alturkistani A, Brindley D, Lam C. Tools for the Diagnosis of Herpes Simplex Virus 1/2: Systematic Review of Studies Published Between 2012 and 2018. JMIR Public Health Surveill. 2019 May 23;5(2):e14216. 32. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337: 509–515. Büchner S, Erni P, Garweg J, et al. Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate. Swiss Medical Weekly. 2004;134(15-16):205–214.

33. Rouse DJ and Stringer JS. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol 2000;183: 400–406 34. Tita AT, Grobman WA and Rouse DJ. Antenatal herpes serologic screening: an appraisal of the evidence. Obstet Gynecol 2006; 108: 1247–1253. 35. Slomka M. J. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. // Commun. Dis. Rep. CDR Rev.1996; 1;6 (3):41– 45.

36. Ковтонюк Г. В., Ганова Л. А., Шепелин К. А. Иммуноферментная тест- система для серодиагностики герпеса 2-го типа. Мед. алфавит. Современная лаборатория. 2013; 3: С. 58 – 60.

37. Liermann K, Schäfler A, Henke A. et al.Evaluation of commercial HSV IgG and IgM enzyme immunoassays. J Virol Methods. 2014;199:29–34.

38. Клинические рекомендации РОДВК по ведению больных инфекциями, передаваемыми половым путем, и урогенитальными инфекциями.: Издательский дом Деловой Экспресс, 2012: 1-112.

39. Carney O, Ross E, Bunker C, et al. A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourin Med 1994; 70: 40–45.

40. Patel R, Tyring S, Strand A, et al. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 1999; 75: 398–402. 23

41. Green J and Kocsis A. Psychological factors in recurrent genital herpes. Genitourin Med 1997; 73: 253–258.

42. Клинические рекомендации ННОИ «Простой герпес у взрослых».: Санкт- Петербург, 2014:1-129.

43. Corey L, Benedetti J, Critchlow C, et al. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983; 12: 79–88.

44. Fife KH, Barbarash RA, Rudolph T, et al. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter,double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis 1997; 24: 481–486.

45. Fife KH, Almekinder J, Ofner S. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir. Sex Transm Dis 2007;34:297-301.

46. Nilsen AE, Aasen T, Halsos AM, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982; 2: 571–573.

47. Reichman RC, Badger GJ, Mertz GJ, Corey L, Richman DD, Connor JD et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA. 1984 Apr 27;251(16):2103-7.

48. Spruance SL, Tyring SK, DeGregorio B, et al. A largescale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med 1996; 156: 1729–1735.

49. Sacks SL, Aoki FY, Diaz-Mitoma F, et al. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA 1996; 276: 44–49.

50. Lebrun-Vignes B, Bouzamondo A, Dupuy A, et al. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. J Am Acad Dermatol 2007; 57: 238–246.

51. Mertz GJ 1 , Jones CC , Mills J , Fife KH , Lemon SM , Stapleton JT et al Long- term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA. 1988 Jul 8;260(2):201-6.

52. Mindel A, Faherty A, Carney O, et al. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988; 1: 926–928. 24

53. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD Jr. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003;102: 1396–403.

54. Mertz GJ. Management of genital herpes. Adv Exp Med Biol. 1996;394: 1-10.

55. Leone PA, Trottier S, Miller JM. Valaciclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002; 34: 958-6.

56. Рахматулина М.Р. Эпизодическая терапия рецидивирующей герпетической инфекции: результаты проспективного постмаркетингового исследования. Вестник дерматологии и венерологии,2009; No5: С. 120-124.

57. Wald A, Carrell D, Remington M, et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002; 34: 944–948.

58. Aoki FY, Tyring S, Diaz-Mitoma F, et al. Single-day,patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2006; 42: 8–13.

59. Abudalu M, Tyring S, Koltun W, et al. Single-day,patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized double- blind, comparative trial. Clin Infect Dis 2008; 47: 651–658.

60. Strand A, Patel R, Wulf HC, et al. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir. Sex Transm Infect2002; 78: 435– 439.

61. Bodsworth N, Bloch M, McNulty A, et al. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study. Sex Health 2008; 5:219– 225.

62. Sacks SL. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in controlled, parallel-group, single-center trial. J Infect Dis 2004 189 (8): 1341-7.

63. Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo- controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003; 188: 836–843.

64. Scott LL, Hollier LM, McIntire D, et al. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 2002; 10: 71–77. 25

65. Brocklehurst P, Kinghorn G, Carney O, et al. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 1998; 105: 275–280.

66. Scott LL, Sanchez PJ, Jackson GL, et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 87: 69–73.

67. Braig S, Luton D, Sibony O, et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol. 2001; 96: 55–58.

68. ACOG Committee on Practice Bulletins. ACOG practice bulletin: clinical management guidelines for obstetriciangynecologists. No. 82, June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007;109:1489-98.

69. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplx virus (HSV) recurrences and neonatal infection. Cochrane Database of Systematic Reviews 2008, Issue 1.

70. Kesson AM. “Management of neonatal herpes simplex virus infection,” Paediatric Drugs, 2001; vol. 3, no. 2: pp. 81–90. 71. Cardamakis E., Relakis K., Kotoulas I.G. et al. Treatment of recurrent genital herpes with interferon alpha-2alpha. Gynecol. Obstet. Invest. 1998; 46(1): Р. 54 – 57.

72. Granados Loarca E.A., Estrada Barrondo E.A. Treatment of genital herpes with alfa2b interferon. Actas. Urol. Esp. 2000; 24(5): Р. 388 – 392.

73. Lassus A., Bergelin I., Paloranta A., et al. Efficacy of interferon and placebo in the treatment of recurrent genital herpes: a double-blind trial. Sex Transm Dis. 1987 Oct- Dec;14(4):185-90. Sex Transm Dis. 1987 Oct-Dec;14(4):185-90.

74. Деленян Н.В., Ариненко Р.Ю., Мешкова Е.Н. Виферон. Комплексный противовирусный и иммуномодулирующий препарат для детей и взрослых. Руководство для врачей. М.: ИНКО-ТНК, 2002: 52 с.

75. Шперлинг И.А., Венгеровский А.И., Шперлинг Н.В. Фармакологическая коррекция индукторами интерферона цитокиновых нарушений при рецидивирующем генитальном герпесе. Эксперим. и клин. Фармакология. 2010; 73(8):С. 39 – 42.

76. Рахматулина М.Р. Комбинированная терапия больных рецидивирующей аногенитальной герпетической инфекцией. Антибиотики и химиотерапия. 2011; 56 (11- 12): С. 25 – 29.

77. Magaret AS, Mujugira A, Hughes JP, et al. Effect of condom use on per-act HSV- 2 transmission risk in HIV-1, HSV-2-discordant couples. Clin Infect Dis 2016;62: 456-61. 26

78. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med 2009;169:1233-40.

79. Sheffield JS, Hill JB, Hollier LM, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006;108:141-7.

80. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9.

81. Parmar H. Pediatric intracranial infections / Parmar H., Ibrahim M. // Neuroimaging Clin N Am. –2012. –Vol. 22. –No 4. –Р. 707-725.

82. Arias-Santiago S, Girón-Prieto MS, Husein-El-Ahmed H, Fernández-Pugnaire MA, Naranjo-Sintes R. Answer: Can you identify this condition?. Can Fam Physician. 2010;56(12):1304–1306.

83. Centers for Disease Control and Prevention. 2015 sexually transmitted diseases treatment guidelines: genital HSV infections. http://www.cdc.gov/std/tg2015/herpes.htm. Accessed March 1, 2016.

84. Johnston C, Morrow RA, Moreland A, Wald A. Genital herpes. In: Morse SA, Ballard RC, Holmes KK, Moreland AA, eds. Atlas of Sexually Transmitted Diseases and AIDS. 4th ed. London, UK: Saunders Elsevier; 2010:169–185.

85. Alecu M., Ghyka G.R., Călugăru A., Coman G. (1989) Interferon efficiency in the treatment of herpetic dermatites. I. A double-blind placebo controlled study. Med. Interne, 27(2): 127–135.

86. Crespi H., de Mora E., Pueyo S. et al. (1988) Therapeutic use of human leukocyte interferon in dermatologic disorders caused by herpes simplex virus. Multicenter study. Med. Cutan. Ibero Lat. Am., 16(6): 459–465.

87. Winston D.J., Eron L.J., Ho M. et al. (1988) Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer. Am. J. Med., 85(2): 147– 151.

88. Тареева Т.Г., Антипова И.И., Малиновская В.В. и соавт. (2000) Состояние иммунного и интерферонового статуса новорожденных при виферонотерапии беременных с цитомегаловирусной и герпетической инфекцией. Рос. иммунол. журн., 5(2): 193–202.

89. Carney O., Ross E., Bunker C., Ikkos G., Mindel A. A prospective study of the psychological impact on patients with a first episode of genital herpes // Genitourin. Med. 1994. Vol. 70. No 1. P. 40–45. 27

90. Patel R., Tyring S., Strand A., Price M.J., Grant D.M. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection // Sex. Transm. Infect. 1999. Vol. 75. No 6. P. 398–402.

91. Green J., Kocsis A. Psychological factors in recurrent genital herpes // Genitourin Med. 1997. Vol. 73. No 4. P. 253–258.

92. Иванова В.В. Современные принципы диагностики и лечения перинатальных герпесвирусных инфекций / В.В. Иванова, М.В. Иванова, A.C. Левина и др. // Российский вестник перинатологии и педиатрии. 2008. — Т53, No1. – С. 10-18.

93. Пестрикова Т.Ю., Юрасова Е.А., Юрасов И.В., Котельникова А.В. Современные аспекты тактики при генитальной герпес-вирусной инфекции: обзор литературы // Издание: Гинекология 2018.-N 2.-С.67-73. Библ. 30 назв.

94. Domingues R.B., Lakeman F.D., Mayo M.S. et al. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis J. Clin. Microbiol. 1998; 36: 2229—34.

95. Kimberlin D. Herpes simplex virus, meningitis and encephalitis in neonates . Herpes. 2004; 11 (Suppl. 2): 65—76A.

96. Tyler K.L. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes. 2004; 11(Suppl. 2): 57—64A.

97. Гинекология: национальное руководство: краткое издание. Под ред. ГМ.Савельевой, Г.Т.Сухих, ИБМанухина. М.: ГЭОТАР-Медиа, 2015

98. Пестрикова Т.Ю., Юрасов ИВ., Юрасова ЕА Воспалительные заболевания в гинекологии: практическое руководство. М: Лит-терра, 2009

99. Рис М., Хоуп С., Охлер МК и др. Диагностика и лечение в гинекологии. Проблемный подход. Пер. с англ. под ред. В.Н.Прилепской. М.: ГЭОТАР-Медиа, 2010.

100. Пестрикова Татьяна Юрьевна, Юрасова Елена Анатольевна, Юрасов Игорь Владимирович, Котельникова Анастасия Владимировна Основные принципы ведения пациенток с генитальным герпесом // Гинекология. 2019. No1.

101. Гинекология. Национальное руководство. Под ред. Г М.Савельевой, ГТ.Сухих, ВН.Серова и др. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2017.

102. Пестрикова Т.Ю., Юрасов И.В., ЮрасоваЕ.А. Воспалительные заболевания в гинекологии. М.: Литтерра, 2009.

103. Кузьмин В. Н. Клиническое течение, диагностика и современная адекватная терапия генитального герпеса у женщин // МС. 2011. No7-8. 28

104. Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Kimberlin DWHerpes. 2007 Jun; 14(1):11-6.

105. JamesSH, KimberlinDW, WhitleyRJ Antiviral therapy for herpes virus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. //AntiviralRes. 2009 Sep; 83(3):207-13.

106. Карахалис Л.Ю., Пенжоян Г.А., Пономарев В.В. и соавт. Противорецидивная терапия герпесвирсной инфекции 2 типа. Российский вестник акушера-гинеколога. 2017 (4): 78-81.

107. Кононова И.Н., Обоскалова Т.А., Кузина Т.В. Опыт применения противовирусного препарата Панавир при лечении беременных с генитальными герпесвирусными инфекциями. Российский вестник акушера-гинеколога. 2017 (6): 73-76.

108. Мельникова С.Е., Стовбун С.В., Коробкова Е.В. и соавт. Эффективность применения Панавира у больных с рецидивирующим генитальным герпесом. Российский вестник акушера-гинеколога. 2017 (3): 97-101.

109. Абдрахманов Р.М., Абдрахманов А.Р., Мисбахова А.Г. и соавт. Расширение возможностей лечения урогенитальной герпесвирусной инфекции. Клиническая дерматология и венерология. 2017 (2): 46-50.

110. Cantin E, Tanamachi B., Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 1999; 73: 3418-3423. 111. Sainz B. Jr., Halford W.P. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol., 2002; 76(22): 11541–11550.

112. Рахматулина М.Р. Интерферон-гамма в терапии генитального герпеса. Инфекционные болезни, 2007; No 3: С. 76-79.

113. Иваненко И.Л., Чураков А.А., Никитина В.В., Гладилин Г.П., Веретенников С.И. Лабораторная диагностика наиболее распространенных урогенитальных инфекций, приводящих к бесплодию //Журнал Современные проблемы науки и образования. – 2016. – No 4

114. Sen P., Barton S.E. Genital herpes and its management. BMJ. 2007; 334: P. 1048.(http://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis- of-genital-herpes-simplexvirus-infection/abstract/78

115. Потекаев Н.Н., Жукова О.В., Львов А.Н. и др. Психореабилитация и обучающее консультирование при рецидивирующем простом герпесе: клинические и организационно-методические аспекты Клиническая дерматология и венерология 2018 No2 том 17 стр.5-10. 29 116. Lebrun-Vignes B, Bouzamondo A, Dupuy A, et al. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. J AmAcad Dermatol 2007; 57: 238–246.

117. ACOG Committee on Practice Bulletins. ACOG practice bulletin: clinical management guidelines for obstetriciangynecologists. No. 82, June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007;109:1489-98.

118. Sénat M.-V., Anselem O., Picone O., Renesme L., Sananès N., Vauloup-Fellous C., et al. Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2018; 224:93–101.118

119. Sexually Transmitted Diseases Treatment Guideline. 2006. CDC. MMWR Recomm Rep 2006;55 (RR-11):1-94. 120. Braig S, Luton D, Sibony O, et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol. 2001; 96: 55–58.

121. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol. 2003 Dec; 102(6):1396-403.

122. Sheffield JS, Hill JB, Mollier LM, Laibl VR, Roberts SW, Sachez PJ and Wendel Jr. GD. Valacyclovir prophylaxis to prevent herpes at delivery. Am J Obstet Gynecol 2006; 180:141- 147 123. Acyclovir and Valacyclovir in Pregnancy Registry final report. April 1999. http://pregnancyregistry.gsk.com/acyclovir.html (accessed 2nd September 2016). 124. Andrews WW, Kimberlin DF, Whitley R, Cliver S, Ramsey PS, Deeter R. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol. 2006;194(3):774-81.

125. Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. ObstetGynecol. 2006;108(1)

126. Foley E. et al. Management of genital herpes in pregnancy //London: British Association for Sexual Health and HIV, Royal College of Obstetricians and Gynaecologists. – 2014.

127. David W. Kimberlin, Jill Baley, COMMITTEE ON INFECTIOUS DISEASES; originally published online January 28, 2013;

128. Chayavichitsilp, P.; Buckwalter, J. V; Krakowski, A. C.; Friedlander, S. F. (2009). Herpes Simplex. , 30(4), 119–130. doi:10.1542/pir.30-4-119 30

129. E.BrosetaJ.M.OscaJ.MoreràUrologicalManifestat HerpesZoster//Department ofUrology,La Fe Hospital,Valencia,Spain

130. Кубанова А.А., Кисина В.И. Рациональная фармакотерапия заболеваний кожи и инфекций, передаваемых половым путем

131. Soul-Lawton J, Seaber E, On N, Wootton R, RolanP,Posner J. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob AgentsChemother 1995;39:2759–2764. (Level II-3)

132. Sexually Transmitted Diseases, May 2007, Vol. 34, No. 5, p.297–301 DOI: 10.1097/01.olq.0000237853.69443.71 Copyright © 2007, American Sexually Transmitted Diseases Association All rights reserved.

133. Connell, Elizabeth B. (1989). Barrier Contraceptives. Clinical Obstetrics and Gynecology, 32(2), 377–386. doi:10.1097/00003081-198906000-00022 url to share this paper: https://sci- hub.mksa.top/ Sci-Hub is a project to make knowledge free. support → updates on twitter

134. Straface, Gianluca; Selmin, Alessia; Zanardo, Vincenzo; De Santis, Marco; Ercoli, Alfredo; Scambia, Giovanni (2012). Herpes Simplex Virus Infection in Pregnancy. Infectious Diseases in Obstetrics and Gynecology, 2012(), 1–6. doi:10.1155/2012/385697

135. Доброхотова Юлия Эдуардовна Боровкова Екатерина Игоревна Герпес-вирусная инфекция: эпидемиология, диагностика, терапия//Гинекология 2017

136. . Кузьмин В. Н., Музыкантова В. С., Семенова Т. Б., Ильенко Л. Н. Герпетическая инфекция в акушерстве и перинатологии. М., 1999. С. 27.

137. Новикова С. В., Малиновская В. В., Бочарова И. И. Современные подходы к определению лечебной тактики при герпес-вирусной инфекции у беременных. Российский вестник акушера-гинеколога. 2015;15(6):92-95. https://doi.org/10.17116/rosakush201515692-95 138. Адаскевич В. П. Заболевания, передаваемые половым путем. Витебск, 1997. 308 с.